Filing Flows › Biotricity (BTCY) › Q4 FY26 › vs Q4 FY25
Biotricity (BTCY) Q4 FY26 vs Q4 FY25 (year over year)
Biotricity's revenue rose $548K (+15%) from $3.7M in Q4 FY25 to $4.3M in Q4 FY26.
Biotricity, Q4 FY26: revenue $4.3M (+15% year over year), operating margin 16.3%, net loss $324K, operating cash flow −$21K. The chart draws each line against Q4 FY25, the increases inside each band.
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $4.3M | $3.7M | $548K | +15% |
| Net loss | $324K | $1.9M | −$1.6M | -83% |
| Costs & expenses | $4.6M | $5.6M | −$1.1M | -19% |
| Operating costs | $3.6M | $4.6M | −$1.0M | -22% |
| Interest & other, net | $1.0M | $1.1M | −$62K | -6% |
| Cost of revenue | $852K | $724K | $127K | +18% |
| Research & development | $842K | $573K | $269K | +47% |
| SG&A | $1.9M | $3.3M | −$1.4M | -43% |
| Operating cash sources | $324K | $1.9M | −$1.6M | -83% |
| Depreciation | $1K | $1K | $0 | 0% |
| Share-based compensation | $8K | $1.3M | −$1.3M | -99% |
| Working capital & other | $294K | $245K | $50K | +20% |
| Cash used in operations | $21K | $401K | −$380K | -95% |
| Net loss absorbed | $324K | $1.9M | −$1.6M | -83% |
Questions
How much did Biotricity's revenue grow year over year in Q4 FY26?
Biotricity's revenue rose $548K (+15%) from $3.7M in Q4 FY25 to $4.3M in Q4 FY26.